DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Aledort LM.
Factor VIII inhibitor bypassing activity (FEIBA) - addressing safety issues.
Haemophilia 2008;
14 (01) 39-43
We do not assume any responsibility for the contents of the web pages of other providers.